Arabica and robusta coffee futures extended losses this week, hitting multi-month lows, as favorable weather in top grower Brazil and strong shipments from Vietnam point to improving global supplies.
The future of Eddie Bauer's brick-and-mortar presence in North America hangs in the balance as its corporate parent, Catalyst Brands, prepares a potential bankruptcy filing that could shutter the outdoor retailer's entire store network.
A wave of resignations has stripped the U.S. Attorney's Office in Minnesota of its most experienced prosecutors, forcing a handover of the landmark $250 million 'Feeding Our Future' fraud case to newcomers amid broader concerns over the office's stability and capacity.
Elon Musk argues that rapid advances in AI and robotics will soon dismantle traditional labor markets, potentially rendering conventional retirement planning unnecessary in a future of 'universal high income' and extreme abundance.
As Tesla's stock navigates volatile valuations, a growing chorus of investors is betting the company's future lies not just in electric vehicles, but in its emerging high-margin businesses and a pipeline of ambitious projects set to redefine its revenue base by the end of the decade.
OpenAI's proposal to trade its AI software for a cut of future drug revenues faces steep odds, analysts say, as the real bottlenecks in medicine lie far beyond the discovery phase.
Energy giant Drax Group has launched a consultation process that could put hundreds of jobs at risk across its UK and North American operations, as the company shifts its focus towards future energy security and biomass innovation.
Taysha Gene Therapies has dosed the first patient in its pivotal REVEAL trial for TSHA-102 and secured FDA agreement to incorporate data from its earlier ASPIRE study into a future marketing application, marking a significant step in its quest to bring a treatment for Rett syndrome to market.
After years of impressive gains, CBRE Group's stock faces scrutiny. A deep dive into valuation metrics suggests the market may be pricing in excessive optimism, raising questions about future returns for investors.
Sonos stock rallied nearly 5% following a quarterly earnings beat, driven by aggressive cost management. However, a sharp 26% reduction in R&D spending raises questions about the audio company's competitive future amidst a profitable but potentially innovation-starved present.
Amidst market volatility, DPM Metals (TSE:DPM) stands out with robust earnings growth and significant insider buying, signaling strong internal conviction in the company's future.
Elon Musk's move to merge SpaceX and xAI signals a pivotal shift for the tech industry, pointing toward a future where the most ambitious energy, computing, and industrial projects leave Earth's surface.
Former Wall Street analyst Tom Lee, now chairman of BitMine Immersion Technologies, is defending the company's strategy of accumulating Ethereum despite facing over $6 billion in unrealized losses. Lee argues the digital asset treasury is a long-term play on the 'future of finance.'
Sugar futures extended their decline, hitting multi-month and multi-year lows, as analysts project sustained global surpluses driven by robust production in Brazil and India.
As online ad costs surge, a technical revolution in user consent, pioneered in Europe, is quietly reshaping the global ad landscape. U.S. businesses, already grappling with state privacy laws, must integrate compliance with campaign performance to safeguard future marketing efficacy.
Cocoa futures tumbled this week, with prices hitting multi-year lows, as forecasts of robust global supplies collide with persistent consumer resistance to high chocolate prices. Analysts point to a significant market surplus ahead.
Shares in Futura Medical PLC jumped as much as 10% after the company upgraded its 2025 revenue forecast to £1.7 million and reported a robust year-end cash balance, extending its financial runway into late 2026.
Shares in Tertiary Minerals PLC jumped over 40% after the explorer reported significant high-grade silver and copper intercepts from its Mushima North project in Zambia, expanding the known mineralized footprint and boosting prospects for a maiden resource estimate by 2026.
Despite a shrinking global share and punitive trade policies, Europe is attracting renewed pharmaceutical investment. Companies are betting on its regulatory rigor, regional diversification strategies, and deep scientific heritage to secure future supply chains.
Merck & Co. posted strong 2025 sales but offered a 2026 revenue forecast below Wall Street's expectations. Despite this, its shares have rallied sharply over the past year, leading analysts to question whether the market is pricing in future pipeline success or overlooking near-term headwinds.
